Exploratory endpoints
Cancer
CANCER
Patients who consent will, in addition to the clinical protocol, be included in the national Danish BIOmarkers in patients with PAncreatic Cancer (BIOPAC) protocol (NCT03311776) with blood samples for research taken at regular intervals [